1859

San Diego, United States

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

$40.0M raised

Feb 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has 1859 raised?

1859 has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in February 2022.

Who are 1859's investors?

1859's investors include Vertical Venture Partners, OMX Ventures, FusionX Ventures, Northpond Ventures.

Where is 1859 headquartered?

1859 is headquartered in San Diego, United States.

What does 1859 do?

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

What stage is 1859 at?

1859 is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 7, 2022.

MLA

"1859 — Funding & Investors." VCBacked, February 7, 2022, https://www.vcbacked.co/company/1859. Accessed July 2, 2026.

APA

VCBacked. (2022). 1859 — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/1859

Wikipedia (cite web)

{{cite web |title=1859 — Funding & Investors |url=https://www.vcbacked.co/company/1859 |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 7, 2022.